期刊文献+
共找到217篇文章
< 1 2 11 >
每页显示 20 50 100
The role of temporary mechanical circulatory support in de novo heart failure syndromes with cardiogenic shock:A contemporary review 被引量:1
1
作者 Stavros Eftychiou Antonis Kalakoutas Alastair Proudfoot 《Journal of Intensive Medicine》 CSCD 2023年第2期89-103,共15页
Cardiogenic shock(CS)is a complex clinical syndrome with a high mortality rate.It can occur to due to multiple etiologies of cardiovascular disease and is phenotypically heterogeneous.Acute myocardial infarction-relat... Cardiogenic shock(CS)is a complex clinical syndrome with a high mortality rate.It can occur to due to multiple etiologies of cardiovascular disease and is phenotypically heterogeneous.Acute myocardial infarction-related CS(AMI-CS)has historically been the most prevalent cause,and thus,research and guidance have focused primarily on this.Recent data suggest that the burden of non-ischemic CS is increasing in the population of patents requiring intensive care admission.There is,however,a paucity of data and guidelines to inform the management of these patients who fall into two broad groups:those with existing heart failure and CS and those with no known history of heart failure who present with"de novo"CS.The use of temporary mechanical circulatory support(MCS)has expanded across all etiologies,despite its high cost,resource intensity,complication rates,and lack of high-quality outcome data.Herein,we discuss the currently available evidence on the role of MCS in the management of patients with de novo CS to include fulminant myocarditis,right ventricular(RV)failure,Takotsubo syndrome,post-partum cardiomyopathy,and CS due to valve lesions and other cardiomyopathies. 展开更多
关键词 cardiogenic shock heart failure Critical care Mechanical circulatory support Takotsubo cardiomyopathy Peripartum cardiomyopathy
原文传递
Temporary coronary sinus pacing to improve ventricular dyssynchrony with cardiogenic shock: A case report
2
作者 Teressa Reanne Ju Hsin Tseng +3 位作者 Hsin-Ti Lin Alexander Lee Wang Chi Chan Lee Yi-Ching Lai 《World Journal of Clinical Cases》 SCIE 2021年第20期5562-5567,共6页
BACKGROUND Temporary transvenous pacing through the coronary sinus is a novel approach rarely used in treating unstable bradycardia.This modality could provide cardiac pacing while achieving better ventricular synchro... BACKGROUND Temporary transvenous pacing through the coronary sinus is a novel approach rarely used in treating unstable bradycardia.This modality could provide cardiac pacing while achieving better ventricular synchrony.We present a case who received cardiac pacing through the coronary sinus and provide a summary of evidence in the current literature.CASE SUMMARY A 55-year-old woman with a history of advanced heart failure was admitted to the rehabilitation ward after a recent stroke.During hospitalization,she had paroxysmal atrial fibrillation with rapid ventricular response resulting from fluid overload.While atrial fibrillation was spontaneously reversed to sinus rhythm after diuresis,she developed multiple episodes of polymorphic ventricular tachycardia along with sinus bradycardia and prolonged QTc interval.She became hypotensive despite appropriate medical management.Pacing through her implantable cardioverter-defibrillator was attempted but worsened her hypotension.Ventricular dyssynchrony was suspected.Temporary transvenous atrial pacing through the coronary sinus was performed,which stabilized her blood pressure and improved end-organ perfusion.A permanent biventricular pacemaker was later implanted,and she was safely discharged to a nursing home.CONCLUSION Temporary transvenous pacing through the coronary sinus,a novel approach to treat unstable bradycardia,may reduce ventricular dyssynchrony. 展开更多
关键词 Cardiac resynchronization Artificial pacemaker Coronary sinus heart failure cardiogenic shock Case report
下载PDF
Impact of heart failure on outcomes in patients with sepsis:A systematic review and meta-analysis
3
作者 Ming-Yu Zhu Xiao-Kai Tang +2 位作者 Yi Gao Jing-Jing Xu Yuan-Qi Gong 《World Journal of Clinical Cases》 SCIE 2023年第15期3511-3521,共11页
BACKGROUND Heart failure(HF)often affects the progress of sepsis patients,although its impact on outcomes is inconsistent and inconclusive.AIM To conduct a systematic review and meta-analysis of the impact of HF on mo... BACKGROUND Heart failure(HF)often affects the progress of sepsis patients,although its impact on outcomes is inconsistent and inconclusive.AIM To conduct a systematic review and meta-analysis of the impact of HF on mortality in patients with sepsis.METHODS PubMed,Embase,Web of Science,and the Cochrane Library databases were searched to compare the outcomes of sepsis patients with HF.A random effect model was used to summarize the mortality data,and the odds ratio(OR)and 95%confidence interval(CI)were calculated as effect indicators.RESULTS Among 18001 records retrieved in the literature search,35712 patients from 10 separate studies were included.The results showed that sepsis patients with HF were associated with increased total mortality(OR=1.80,95%CI:1.34-2.43;I2=92.1%),with high heterogeneity between studies.Significant subgroup differences according to age,geographical location,and HF patient sample were observed.HF did not increase the 1-year mortality of patients(OR=1.11,95%CI:0.75-1.62;I2=93.2%),and the mortality of patients with isolated right ventricular dysfunction(OR=2.32,95%CI:1.29-4.14;I2=91.5%)increased significantly.CONCLUSION In patients with sepsis,HF is often associated with adverse outcomes and mortality.Our results call for more high-quality research and strategies to improve outcomes for sepsis patients with HF. 展开更多
关键词 heart failure SEPSIS Septic shock PROGNOSIS META-ANALYSIS
下载PDF
Percutaneous assist devices in acute myocardial infarction with cardiogenic shock: Review, meta-analysis 被引量:31
4
作者 Francesco Romeo Maria Cristina Acconcia +4 位作者 Domenico Sergi Alessia Romeo Simona Francioni Flavia Chiarotti Quintilio Caretta 《World Journal of Cardiology》 CAS 2016年第1期98-111,共14页
AIM: To assess the impact of percutaneous cardiac support in cardiogenic shock(CS) complicating acute myocardial infarction(AMI), treated with percutaneous coronary intervention. METHODS: We selected all of the studie... AIM: To assess the impact of percutaneous cardiac support in cardiogenic shock(CS) complicating acute myocardial infarction(AMI), treated with percutaneous coronary intervention. METHODS: We selected all of the studies published from January 1st, 1997 to May 15 st, 2015 that compared the following percutaneous mechanical support in patients with CS due to AMI undergoing myocardial revascularization:(1) intra-aortic balloon pump(IABP) vs Medical therapy;(2) percutaneous left ventricular assist devices(PLVADs) vs IABP;(3) complete extracorporeal life support with extracorporeal membrane oxygenation(ECMO) plus IABP vs IABP alone; and(4) ECMO plus IABP vs ECMO alone, in patients with AMI and CS undergoing myocardial revascularization. We evaluated the impact of the support devices on primary and secondary endpoints. Primary endpoint was the inhospital mortality due to any cause during the same hospital stay and secondary endpoint late mortality at 6-12 moof follow-up. RESULTS: One thousand two hundred and seventytwo studies met the initial screening criteria. After detailed review, only 30 were selected. There were 6 eligible randomized controlled trials and 24 eligible observational studies totaling 15799 patients. We found that the inhospital mortality was:(1) significantly higher with IABP support vs medical therapy(RR = +15%, P = 0.0002);(2) was higher, although not significantly, with PLVADs compared to IABP(RR = +14%, P = 0.21); and(3) significantly lower in patients treated with ECMO plus IABP vs IABP(RR =-44%, P = 0.0008) or ECMO(RR =-20%, P = 0.006) alone. In addition, Trial Sequential Analysis showed that in the comparison of IABP vs medical therapy, the sample size was adequate to demonstrate a significant increase in risk due to IABP. CONCLUSION: Inhospital mortality was significantly higher with IABP vs medical therapy. PLVADs did not reduce early mortality. ECMO plus IABP significantly reduced inhospital mortality compared to IABP. 展开更多
关键词 Intra-aortic balloon pump IMPELLA Tandem heart EXTRACORPOREAL membrane OXYGENATION cardiogenic shock META-ANALYSIS
下载PDF
Hypoglycemic myocardial stunning as cause of cardiogenic shock in a patient with ischemic cardiomyopathy: A case report and review of literature
5
作者 Khawar Maqsood Ghazi Mirrani +3 位作者 Nosheen Sarwar Amatur R. Amarah Muhammad Rizwan Sardar Timothy A. Shapiro 《Case Reports in Clinical Medicine》 2013年第1期89-92,共4页
Hypoglycemia is a common complication seen in patients with diabetes mellitus and has been proven to have adverse effects on cardiovascular mortality. Hypoglycemia can potentially lead to worsening of cardiac function... Hypoglycemia is a common complication seen in patients with diabetes mellitus and has been proven to have adverse effects on cardiovascular mortality. Hypoglycemia can potentially lead to worsening of cardiac function in patients with ischemic heart disease. We present a case of cardiogenic shock in a patient with hypoglycemia secondary to insulin accumulation due to worsening renal function with dramatic recovery of shock once his sugars normalized. 展开更多
关键词 Chronic heart failure HYPOGLYCEMIA Myocardial STUNNING ISCHEMIC CARDIOMYOPATHY cardiogenic shock
下载PDF
Impact of initial fluid resuscitation volume on clinical outcomes in patientswith heart failure and septic shock
6
作者 Adam L.Wiss Bruce A.Doepker +5 位作者 Brittany Hoyte Logan M.Olson Kathryn A.Disney Eric M.McLaughlin Vincent Esguerra Jessica L.Elefritz 《Journal of Intensive Medicine》 CSCD 2023年第3期254-260,共7页
Background:Fluid resuscitation is a key treatment for sepsis,but limited data exists in patients with existing heartfailure(HF)and septic shock.The objective of this study was to determine the impact of initial fluid ... Background:Fluid resuscitation is a key treatment for sepsis,but limited data exists in patients with existing heartfailure(HF)and septic shock.The objective of this study was to determine the impact of initial fluid resuscitationvolume on outcomes in HF patients with reduced or mildly reduced left ventricular ejection fraction(LVEF)withseptic shock.Methods:This multicenter,retrospective,cohort study included patients with known HF(LVEF≤50%)presentingwith septic shock.Patients were divided into two groups based on the volume of fluid resuscitation in the first 6 h;<30 mL/kg or≥30 mL/kg.The primary outcome was a composite of in-hospital mortality or renal replacementtherapy(RRT)within 7 days.Secondary outcomes included acute kidney injury(AKI),initiation of mechanicalventilation,and length of stay(LOS).All related data were collected and compared between the two groups.A generalized logistic mixed model was used to assess the association between fluid groups and the primaryoutcome while adjusting for baseline LVEF,Acute Physiology and Chronic Health Evaluation(APACHE)II score,inappropriate empiric antibiotics,and receipt of corticosteroids.Results:One hundred and fifty-four patients were included(93 patients in<30 mL/kg group and 61 patientsin≥30 mL/kg group).The median weight-based volume in the first 6 h was 17.7(12.2–23.0)mL/kg in the<30 mL/kg group vs.40.5(34.2–53.1)mL/kg in the≥30 mL/kg group(P<0.01).No statistical difference was detected in the composite of in-hospital mortality or RRT between the<30 mL/kg group compared to the≥30 mL/kggroup(55.9%vs.45.9%,P=0.25),respectively.The<30 mL/kg group had a higher incidence of AKI,mechanicalventilation,and longer hospital LOS.Conclusions:In patients with known reduced or mildly reduced LVEF presenting with septic shock,no differencewas detected for in-hospital mortality or RRT in patients who received≥30 mL/kg of resuscitation fluid comparedto less fluid,although this study was underpowered to detect a difference.Importantly,≥30 mL/kg fluid did notresult in a higher need for mechanical ventilation. 展开更多
关键词 SEPSIS Septic shock heart failure Fluid resuscitation
原文传递
Elevated level of high-sensitivity cardiac troponin I as a predictor of adverse cardiovascular events in patients with heart failure with preserved ejection fraction
7
作者 Hongyu Hu Jingjin Li +2 位作者 Xin Wei Jia Zhang Jiayu Wang 《Chinese Medical Journal》 SCIE CAS CSCD 2023年第18期2195-2202,共8页
Background:The relationship between the elevation of cardiac troponin and the increase of mortality and hospitalization rate in patients with heart failure with reduced ejection fraction is clear.This study investigat... Background:The relationship between the elevation of cardiac troponin and the increase of mortality and hospitalization rate in patients with heart failure with reduced ejection fraction is clear.This study investigated the association between the extent of elevated levels of high-sensitivity cardiac troponin I(hs-cTnI)and the prognosis in heart failure with preserved ejection fraction patients.Methods:A retrospective cohort study consecutively enrolled 470 patients with heart failure with preserved ejection fraction from September 2014 to August 2017.According to the level of hs-cTnI,the patients were divided into the elevated level group(hs-cTnI>0.034 ng/mL in male and hs-cTnI>0.016 ng/mL in female)and the normal level group.All of the patients were followed up once every 6 months.Adverse cardiovascular events were cardiogenic death and heart failure hospitalization.Results:The mean follow-up period was 36.2±7.9 months.Cardiogenic mortality(18.6%[26/140]vs.1.5%[5/330],P<0.001)and heart failure(HF)hospitalization rate(74.3%[104/140]vs.43.6%[144/330],P<0.001)were significantly higher in the elevated level group.The Cox regression analysis showed that the elevated level of hs-cTnI was a predictor of cardiogenic death(hazard ratio[HR]:5.578,95%confidence interval[CI]:2.995-10.386,P<0.001)and HF hospitalization(HR:3.254,95%CI:2.698-3.923,P<0.001).The receiver operating characteristic curve demonstrated that a sensitivity of 72.6%and specificity of 88.8%for correct prediction of adverse cardiovascular events when a level of hs-cTnI of 0.1305 ng/mL in male and a sensitivity of 70.6%and specificity of 90.2%when a level of hs-cTnI of 0.0755 ng/mL in female were used as the cut-off value.Conclusion:Significant elevation of hs-cTnI(≥0.1305 ng/mL in male and≥0.0755 ng/mL in female)is an effective indicator of the increased risk of cardiogenic death and HF hospitalization in heart failure with preserved ejection fraction patients. 展开更多
关键词 heart failure with preserved ejection fraction High-sensitivity cardiac troponin I cardiogenic mortality heart failure hospitalization
原文传递
Remote monitoring of implantable defibrillators is associated with fewer inappropriate shocks and reduced time to medical assessment in a remote and rural area 被引量:2
8
作者 Kara Callum Claudia Graune +2 位作者 Elizabeth Bowman Edward Molden Stephen J Leslie 《World Journal of Cardiology》 2021年第3期46-54,共9页
BACKGROUND Implantable cardioverter defibrillators(ICDs)and cardiac resynchronisation therapy with defibrillators(CRT-D)reduce mortality in certain cardiac patient populations.However,inappropriate shocks pose a probl... BACKGROUND Implantable cardioverter defibrillators(ICDs)and cardiac resynchronisation therapy with defibrillators(CRT-D)reduce mortality in certain cardiac patient populations.However,inappropriate shocks pose a problem,having both adverse physical and psychological effects on the patient.The advances in device technology now allow remote monitoring(RM)of devices to replace clinic follow up appointments.This allows real time data to be analysed and actioned and this may improve patient care.AIM To determine if RM in patients with an ICD is associated with fewer inappropriate shocks and reduced time to medical assessment.METHODS This was a single centre,retrospective observational study,involving 156 patients implanted with an ICD or CRT-D,followed up for 2 years post implant.Both appropriate and inappropriate shocks were recorded along with cause for inappropriate shocks and time to medical assessment.RESULTS RM was associated with fewer inappropriate shocks(13.6%clinic vs 3.9%RM;P=0.030)and a reduced time to medical assessment(15.1±6.8 vs 1.0±0.0 d;P<0.001).CONCLUSION RM in patients with an ICD is associated with improved patient outcomes. 展开更多
关键词 Implantable cardioverter defibrillator Inappropriate shocks Remote monitoring Cardiac patients heart failure ARRYTHMIA
下载PDF
Over-expression of heat shock protein 27 attenuates doxorubicin-induced cardiac dysfunction in mice 被引量:15
9
作者 Liu,L Zhang,X +5 位作者 Qian,B Min,XY Gao,X Li,CF Cheng,YL Huang,J 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2007年第11期1239-1239,共1页
关键词 过表达 热休克蛋白 阿霉素 心脏功能紊乱
下载PDF
衰弱对老年射血分数减低的心力衰竭患者的影响 被引量:1
10
作者 宗敏 关晓楠 +1 位作者 常晶 张建军 《中华老年心脑血管病杂志》 CAS 北大核心 2024年第5期523-526,共4页
目的探讨衰弱对老年射血分数减低的心力衰竭(HFrEF)患者的长期影响。方法回顾性分析2017年10月至2020年10月因慢性心力衰竭急性加重于首都医科大学附属北京朝阳医院心内科住院治疗的年龄≥75岁的HFrEF患者245例,根据临床衰弱量表(CFS)... 目的探讨衰弱对老年射血分数减低的心力衰竭(HFrEF)患者的长期影响。方法回顾性分析2017年10月至2020年10月因慢性心力衰竭急性加重于首都医科大学附属北京朝阳医院心内科住院治疗的年龄≥75岁的HFrEF患者245例,根据临床衰弱量表(CFS)评分分为衰弱组(CFS 1~4分)135例和非衰弱组(CFS 5~9分)110例,比较2组的一般临床资料、临床用药以及预后,并且分析衰弱与死亡的相关影响因素。结果衰弱组心率、N末端B型钠尿肽前体、男性、糖尿病、冠心病、≥5种慢性病、左心室射血分数(LVEF)≤35%、贫血、肌钙蛋白I升高比例高于非衰弱组(P<0.05,P<0.01),体质量指数(BMI)、估算肾小球滤过率(eGFR)、日常生活活动能力量表评分低于非衰弱组(P<0.05,P<0.01)。衰弱组应用血管紧张素转换酶抑制剂、血管紧张素受体阻滞剂、血管紧张素受体脑啡肽酶抑制剂、β受体阻滞剂、钠-葡萄糖协同转运蛋白2抑制剂比例低于非衰弱组(P<0.01),衰弱组3个月内急诊/再住院、2年内死亡比例高于非衰弱组(P<0.05,P<0.01)。二元logistic回归分析显示,≥5种慢性病、LVEF≤35%、BMI、GFR为影响衰弱的独立危险因素(OR=0.167,95%CI:0.064~0.453,P=0.000;OR=0.306,95%CI:0.160~0.586,P=0.000;OR=0.868,95%CI:0.786~0.958,P=0.005;OR=0.966,95%CI:0.943~0.991,P=0.007),而≥5种慢性病、衰弱为影响心力衰竭患者死亡的独立危险因素(P<0.05)。结论衰弱在老年HFrEF患者中发病率高,衰弱患者不易接受指南引导药物治疗,是老年HFrEF心力衰竭患者远期病死率的独立危险因素。 展开更多
关键词 心肌梗死 休克 心源性 危险因素 心力衰竭 衰弱
下载PDF
基层医院急诊经导管主动脉瓣置换术治疗主动脉瓣狭窄合并急性心力衰竭休克患者1例
11
作者 郭寰 李育东 +4 位作者 董念国 尚小珂 钟禹成 张长东 张凌波 《中国介入心脏病学杂志》 CSCD 2024年第5期291-294,共4页
主动脉瓣狭窄作为常见的心脏瓣膜病病情进展快、临床预后差。在合并急性心力衰竭的情况下,心脏泵血功能严重受损,可能导致心脏输出量显著减少,从而引起休克。经导管主动脉瓣置换术(TAVR)自2002年首例成功以来,已成为老年主动脉瓣狭窄患... 主动脉瓣狭窄作为常见的心脏瓣膜病病情进展快、临床预后差。在合并急性心力衰竭的情况下,心脏泵血功能严重受损,可能导致心脏输出量显著减少,从而引起休克。经导管主动脉瓣置换术(TAVR)自2002年首例成功以来,已成为老年主动脉瓣狭窄患者的一线治疗手段。在国内,随着技术的进步和医师培训的加强,基层医院在TAVR治疗方面的能力正在增强。本病例报道1例伴有急性心力衰竭休克的重度主动脉瓣狭窄患者在基层医院接受急诊TAVR治疗。因条件限制,在不备体外循环及体外膜肺氧合支持下紧急实施了TAVR。患者术中扩张瓣膜后血压即升至105/65 mmHg,术后症状明显缓解,复查心脏彩色多普勒超声示狭窄解除,心功能明显改善。本例手术的成功为基层医院重度主动脉瓣狭窄合并心力衰竭患者行急诊TAVR治疗提供了一定的借鉴。 展开更多
关键词 经导管主动脉瓣置换术 低左心室射血分数 心原性休克 经皮冠状动脉介入治疗 心力衰竭
下载PDF
终末期心力衰竭机械循环支持的治疗进展 被引量:3
12
作者 陈静 吴明祥 苏晞 《中国心血管杂志》 北大核心 2024年第1期17-26,共10页
心脏的机械循环支持(MCS)是代替或辅助心脏功能、向心外提供血液灌注、改善机体缺氧状态、促进器官功能恢复的人工器械。在过去的20年中,MCS更多地应用于心力衰竭程度更严重、合并症更复杂的患者,同时还包括因急性心肌梗死或心脏骤停而... 心脏的机械循环支持(MCS)是代替或辅助心脏功能、向心外提供血液灌注、改善机体缺氧状态、促进器官功能恢复的人工器械。在过去的20年中,MCS更多地应用于心力衰竭程度更严重、合并症更复杂的患者,同时还包括因急性心肌梗死或心脏骤停而紧急复苏的心原性休克患者。近年来,随着终末期心力衰竭患病率的持续上升及此类患者因心功能受限所致生活质量的严重下降,且对这类患者的药物治疗无效,使以心室辅助装置应用为主的MCS日渐成为顽固性心力衰竭患者的一种重要替代治疗手段。 展开更多
关键词 机械循环支持 心室辅助装置 心原性休克 终末期心力衰竭
下载PDF
充血性心力衰竭合并心源性休克患者的院内死亡预测模型构建及临床效能分析
13
作者 孙铁男 李志忠 《中国医药》 2024年第11期1615-1619,共5页
目的基于重症监护医学信息数据库(MIMIC)构建一个预测充血性心力衰竭合并心源性休克(CS)患者院内死亡的模型并评价其临床效能。方法本研究为回顾性研究,纳入MIMIC-Ⅳ中2008—2019年诊断为充血性心力衰竭合并CS的患者2090例,根据是否发... 目的基于重症监护医学信息数据库(MIMIC)构建一个预测充血性心力衰竭合并心源性休克(CS)患者院内死亡的模型并评价其临床效能。方法本研究为回顾性研究,纳入MIMIC-Ⅳ中2008—2019年诊断为充血性心力衰竭合并CS的患者2090例,根据是否发生院内死亡,将所有患者分为非死亡组(1434例)及死亡组(656例)。收集患者的临床特征、生命体征、实验室检查结果及系统评分等数据。通过Lasso回归筛选相关变量,并采用多因素Logistic回归分析独立预测因素,构建院内死亡的列线图预测模型。使用Bootstrap法进行内部验证,并通过受试者工作特征(ROC)曲线分析和决策曲线分析(DCA)对预测模型进行评价。结果多因素Logistic回归分析结果显示,末梢血氧饱和度[比值比=0.968,95%置信区间(CI):0.949~0.987,P=0.001]和血白蛋白(比值比=0.764,95%CI:0.626~0.932,P=0.008)为院内死亡的独立保护因素;年龄(比值比=1.043,95%CI:1.034~1.051,P<0.001)、女性(比值比=1.304,95%CI:1.052~1.615,P=0.015)、体温<36℃(比值比=1.720,95%CI:1.284~2.304,P<0.001)、慢性阻塞性肺疾病(比值比=1.404,95%CI:1.131~1.744,P=0.002)、血液透析(比值比=2.210,95%CI:1.710~2.856,P<0.001)、血乳酸(比值比=1.149,95%CI:1.100~1.200,P<0.001)、序贯器官衰竭评估评分(比值比=1.113,95%CI:1.080~1.146,P<0.001)为院内死亡的独立危险因素。基于多因素Logistic回归分析构建充血性心力衰竭合并CS患者院内死亡的列线图风险模型,ROC曲线下面积为0.766,敏感度为72.6%,特异度为66.9%。内部验证的重抽样校准曲线表明模型理想曲线和实际曲线拟合良好。DCA表明该模型具有较高的临床净获益。结论本研究基于MIMIC-Ⅳ,通过年龄、性别、慢性阻塞性肺疾病、末梢血氧饱和度、体温<36℃、血液透析、血白蛋白、血乳酸、序贯器官衰竭评估评分构建了充血性心力衰竭合并CS患者的院内死亡列线图预测模型。该模型具有较高区分度、校准度、预测效能以及临床净获益,能帮助早期识别高风险患者,并优化治疗决策。 展开更多
关键词 心源性休克 充血性心力衰竭 院内死亡 预测模型
下载PDF
银发世代心源性休克的临床诊治特征与多学科整合精准管理
14
作者 章晓红 郑薇 +2 位作者 朱光亚 王建 李炀 《西南医科大学学报》 2024年第5期377-383,共7页
心源性休克(cardiogenic shock,CS)是指由于心脏泵血功能受损导致心脏无法向全身组织输送足够量的血液,从而无法满足组织代谢需求的临床综合征。临床上,主要由急性心肌梗塞(acute myocardial infarction,AMI)与急性失代偿心力衰竭(acute... 心源性休克(cardiogenic shock,CS)是指由于心脏泵血功能受损导致心脏无法向全身组织输送足够量的血液,从而无法满足组织代谢需求的临床综合征。临床上,主要由急性心肌梗塞(acute myocardial infarction,AMI)与急性失代偿心力衰竭(acutely decompensated heart failure,ADHF)引起。近年来,随着人口老龄化进程加速,老年人心源性休克发病率逐年增加,其中急性失代偿心衰相关性心源性休克(heart failure related CS,HF-CS)取代急性心肌梗死后心源性休克(acute myocardial infarction complicated by cardiogenic shock,AMI-CS),成为老年心脏急重症人“最后战场”。尽管缺乏高质量循证医学证据,机械循环辅助(mechanical circulatory support,MCS),如静脉动脉体外膜氧合(veno-arterial extracorporeal membrane oxygenation,V-A ECMO)在心源性休克患者中的应用越来越多。但心脏移植和持久左心室辅助设备在老年心源性休克的应用仍是禁区。为此,2024年2月26日,美国心脏协会(AHA)于Circulation发表针对老年CS的科学声明:①年龄是老年心源性休克的高危险因素,但不是唯一,不应用于指导单个患者在心源性休克的管理决策;②老年心源性休克治疗强调跨学科团队的综合评估、医患共同决策。因此,本文就老年心源性休克相关急诊急救最新实践以及CS“休克中心”建设做一解读,希望能够进一步提升对心源性休克患者的多学科整合精准管理。 展开更多
关键词 心源性休克 心力衰竭 老年 年龄
下载PDF
老年慢性心力衰竭患者嗜铬粒蛋白A和热休克转录因子1与心脏损伤的关系
15
作者 马燕 史丽英 +1 位作者 王海雄 郭李平 《中华老年心脑血管病杂志》 CAS 北大核心 2024年第6期619-623,共5页
目的探讨老年慢性心力衰竭(CHF)患者血清嗜铬粒蛋白A(CgA)和热休克转录因子1(HSF1)的水平变化与心肌重构及心肌损伤的关系。方法选择2019年1月至2022年5月太原市中心医院收治的老年CHF患者165例(疾病组),其中纽约心脏病协会心功能分级Ⅰ... 目的探讨老年慢性心力衰竭(CHF)患者血清嗜铬粒蛋白A(CgA)和热休克转录因子1(HSF1)的水平变化与心肌重构及心肌损伤的关系。方法选择2019年1月至2022年5月太原市中心医院收治的老年CHF患者165例(疾病组),其中纽约心脏病协会心功能分级Ⅰ级28例,Ⅱ级29例,Ⅲ级65例和Ⅳ级43例。收集同期本院健康志愿者80例(对照组)。检测2组入院血清CgA和HSF1水平,心肌重构和心肌损伤指标,用Pearson分析血清CgA和HSF1与心肌重构及心肌损伤的相关性。随访1年,失访6例,根据是否发生主要不良心血管事件(MACE)分为MACE组51例和非MACE组108例。用单因素和多因素logistic回归分析,使用ROC曲线分析血清CgA和HSF1对MACE的预测价值。结果疾病组血清CgA、左心室质量指数(LVMI)、左心室收缩末期容积(LVESV)、左心室后壁厚度(LVPWT)、肌钙蛋白I(cTnI)、肌酸激酶同工酶(CK-MB)和N末端B型钠尿肽前体(NT-proBNP)水平显著高于对照组,HSF1和左心室射血分数(LVEF)显著低于对照组,差异有统计学意义(P<0.01)。Pearson相关性分析显示,血清CgA与LVEF呈负相关,与LVMI、LVESV、LVPWT、cTnI、CK-MB和NT-proBNP呈正相关(P<0.01);血清HSF1与LVEF呈正相关,与LVMI、LVESV、LVPWT、cTnI、CK-MB和NT-proBNP呈负相关(P<0.01)。多因素logistic回归分析显示,CgA、HSF1、LVEF、LVMI、LVESV、LVPWT和cTnI是老年CHF患者MACE发生的影响因素(P<0.05,P<0.01)。ROC曲线分析显示,血清CgA截断值为387.55μg/L,敏感性为74.51%,特异性为71.30%,曲线下面积为0.802(95%CI:0.751~0.855);血清HSF1截断值为2.34 ng/L,敏感性为74.51%,特异性为69.44%,曲线下面积为0.760(95%CI:0.707~0.812)。结论老年CHF患者血清CgA和HSF1水平与心肌重构及心肌损伤有密切关联,可作为预测MACE的有力工具。 展开更多
关键词 心力衰竭 嗜铬粒蛋白质A 热休克转录因子 心室重构 心肌损伤
下载PDF
右心衰竭对脓毒性休克容量反应性的影响
16
作者 雷铃 杨春蕾 +1 位作者 吴朝文 陈万 《中国实用医药》 2024年第15期47-49,共3页
目的研究右心衰竭对脓毒性休克容量反应性的影响。方法16例脓毒性休克患者,按照右心衰竭诊断标准将研究对象分为脓毒性休克不合并右心衰竭组(7例)和脓毒性休克合并右心衰竭组(9例)。收集研究对象的一般资料,并进行中心静脉压(CVP)测定... 目的研究右心衰竭对脓毒性休克容量反应性的影响。方法16例脓毒性休克患者,按照右心衰竭诊断标准将研究对象分为脓毒性休克不合并右心衰竭组(7例)和脓毒性休克合并右心衰竭组(9例)。收集研究对象的一般资料,并进行中心静脉压(CVP)测定、重症心脏超声检查。比较两组患者的年龄、性别、急性生理学及慢性健康状况评估系统Ⅱ(APACHEⅡ)评分、序贯器官衰竭评估(SOFA)评分、左室射血分数(LVEF)、右心室舒张末面积(RVEDA)、左心室舒张末面积(LVEDA)、RVEDA/LVEDA、补液前血流速度时间积分(VTI)、补液后VTI、ΔVTI。结果两组年龄、性别、APACHEⅡ评分、SOFA评分、LVEF、LVEDA、补液前VTI、补液后VTI比较无统计学差异(P>0.05)。脓毒性休克不合并右心衰竭组的RVEDA(2.00±0.35)cm2小于脓毒性休克合并右心衰竭组的(2.42±0.35)cm2,RVEDA/LVEDA(0.47±0.03)低于脓毒性休克合并右心衰竭组的(0.62±0.02),ΔVTI(20.83±8.35)%高于脓毒性休克合并右心衰竭组的(11.40±7.06)%,差异有统计学意义(P<0.05)。结论右心衰竭对脓毒性休克容量反应性有影响。 展开更多
关键词 右心衰竭 脓毒性休克 容量反应性
下载PDF
血清CF-6、HSP-70表达对慢性心力衰竭患者病情及预后的评估价值
17
作者 李雅兰 喻洪 《四川医学》 CAS 2024年第5期507-511,共5页
目的探究血清线粒体偶联因子-6(CF-6)、热休克蛋白70(HSP-70)表达对慢性心力衰竭(CHF)患者病情及预后的评估价值。方法选取2020年12月至2021年12月我院收治的CHF患者106例(CHF组),根据美国纽约心脏病协会(NYHA)心功能分级标准分为:NYHA... 目的探究血清线粒体偶联因子-6(CF-6)、热休克蛋白70(HSP-70)表达对慢性心力衰竭(CHF)患者病情及预后的评估价值。方法选取2020年12月至2021年12月我院收治的CHF患者106例(CHF组),根据美国纽约心脏病协会(NYHA)心功能分级标准分为:NYHAⅡ级36例(Ⅱ级组),NYHAⅢ级38例(Ⅲ级组),NYHAⅣ级32例(Ⅳ级组);根据预后情况分为预后良好组54例,预后不良组52例;选择同期我院体检健康的106例志愿者为对照组。采用酶联免疫吸附测定(ELISA)法检测血清中CF-6、HSP-70的表达水平;多因素Logistic回归分析影响CHF预后的危险因素;受试者工作特征(ROC)曲线分析血清中CF-6、HSP-70对CHF预后的评估价值。结果与对照组相比,CHF组血清中CF-6、HSP-70表达水平显著升高(P<0.05)。CHF患者Ⅳ级组血清CF-6、HSP-70表达水平显著高于Ⅱ级组和Ⅲ级组,Ⅲ级组表达水平显著高于Ⅱ级组(P<0.05)。与预后良好组相比,预后不良组CF-6、HSP-70水平显著升高(P<0.05)。预后不良组血肌酐水平显著高于预后良好组(P<0.05)。多因素Logistic回归分析显示,CF-6、HSP-70、血肌酐表达水平是影响CHF预后的危险因素;ROC分析显示,血清CF-6、HSP-70水平联合预测CHF预后的AUC高于CF-6、HSP-70单独预测的AUC值(P<0.05)。结论CHF患者血清CF-6、HSP-70表达水平显著升高,并随着病情加重而升高,二者对CHF患者的预后评估有一定的临床价值。 展开更多
关键词 慢性心力衰竭 线粒体偶联因子-6 热休克蛋白70 预后
下载PDF
重症超声对脓毒性休克合并射血分数保留的心力衰竭患者液体复苏的研究
18
作者 张义强 蔡云 +2 位作者 张雪莹 吕森 李永生 《中国急救复苏与灾害医学杂志》 2024年第2期177-182,共6页
目的 探讨重症超声在脓毒性休克伴HFPEF患者的液体复苏的指导意义。方法 将中山市人民医院南朗分院在2020年9月—2021年10月期间收住院治疗的116例脓毒性休克患者作为研究对象,全部患者在入院时均存在射血分数保留的心力衰竭,随机分为... 目的 探讨重症超声在脓毒性休克伴HFPEF患者的液体复苏的指导意义。方法 将中山市人民医院南朗分院在2020年9月—2021年10月期间收住院治疗的116例脓毒性休克患者作为研究对象,全部患者在入院时均存在射血分数保留的心力衰竭,随机分为对照组和研究组,每组各58例,两组患者均对患者进行液体复苏,按照进行液体复苏的方式分为对照组(常规方式)及研究组(重症超声指导下)。对比两组患者复苏前后血流动力学变化指标,同时对比两组患者在院期间的临床治疗指标。结果 组内比较,平均动脉压、中心静脉压及中心静脉血氧饱和度三项指标在复苏后6 h、24 h后两个时间节点均明显高于复苏前,差异有统计学意义(P<0.05),心率均低于复苏前(P<0.05);与复苏24 h后两组患者平均动脉压、中心静脉压及中心静脉血氧饱和度三项指标比复苏后6 h水平升高,差异有统计学意义(P<0.05),心率均降低(P<0.05);且复苏各时间点研究组平均动脉压、中心静脉压及中心静脉血氧饱和度水平均高于对照组(P<0.05),心率低于对照组(P<0.05);两组血乳酸、血清N末端利钠肽前体水平在复苏前、复苏24 h、复苏48 h、复苏72 h依次降低(P<0.05),且研究组复苏各时间点血乳酸、血清N末端利钠肽前体水平均低于对照组(P<0.05);两组心脏指数、左心室每搏作功指数水平在复苏前、复苏24 h、复苏48 h、复苏72 h依次升高(P<0.05),且研究组复苏各时间点心脏指数、左心室每搏做功指数水平均高于对照组(P<0.05);研究组复苏阶段晶体液总摄入量[(11 317.83±2 158.53) mL vs.(13 254.28±2 759.14) mL]、去甲肾上腺素使用量[(36.16±6.54) mg vs.(47.58±8.21) mg]均低于对照组(P<0.05);研究组患者28 d病死率与对照组比较无统计学意义(3.45%vs.. 5.17%,P>0.05);研究组肺水肿发生率低于对照组(8.62%vs. 22.41%,P<0.05),ICU停留时间短于对照组[(10.61±2.12) d vs.(12.58±2.49) d,P<0.05]。结论 常规治疗与重症超声指导下进行液体复苏进行比较发现,重症超声指导下对脓毒性休克合并HFPEF患者能对患者的血流动力学恢复产生积极作用,同时能有效改善患者的组织灌注,对患者的心功能恢复产生有利作用,并且能够对疾病的预后有积极作用。 展开更多
关键词 重症超声 脓毒性休克 心力衰竭 液体复苏 指导价值
下载PDF
主动脉内球囊反搏泵在经皮冠状动脉介入术不同时机的应用
19
作者 罗佳 张天翼 李杨丹 《医疗装备》 2024年第6期19-22,共4页
目的探讨主动脉内球囊反搏泵(IABP)在急性心肌梗死(AMI)伴心源性休克(CS)患者经皮冠状动脉介入术(PCI)不同时机的应用。方法选取2021年1月至2023年8月于医院拟行PCI治疗的70例AMI伴CS患者,随机分为两组,各35例。两组均给予吸氧、心电监... 目的探讨主动脉内球囊反搏泵(IABP)在急性心肌梗死(AMI)伴心源性休克(CS)患者经皮冠状动脉介入术(PCI)不同时机的应用。方法选取2021年1月至2023年8月于医院拟行PCI治疗的70例AMI伴CS患者,随机分为两组,各35例。两组均给予吸氧、心电监护、基础药物及急诊PCI治疗。试验组和对照组分别于PCI术前和术后置入IABP。比较两组术前和术后24 h的血流动力学指标[平均动脉压(MAP)、心率(HR)和尿量]水平,术前和术后7 d的心肌损伤标志物[血清肌酸激酶同工酶(CK-MB)和肌钙蛋白I(cTnI)]水平,术前和术后3个月的心功能指标[左心室射血分数(LVEF)、肺毛细血管契压(PCWP)和心脏指数(CI)]水平,以及术后30 d内的病死率。结果术后24 h,两组MAP和尿量均高于术前,HR低于术前,且试验组MAP和尿量均高于对照组,HR低于对照组,差异均有统计学意义(P<0.05);术后7 d,两组血清CK-MB和cTnI水平均低于术前,且试验组低于对照组,差异均有统计学意义(P<0.05);术后3个月,两组LVEF和CI水平均高于术前,PCWP水平均低于术前,且试验组LVEF和CI水平高于对照组,PCWP水平低于对照组,差异均有统计学意义(P<0.05)。术后30 d内,两组病死率比较,差异无统计学意义(P>0.05)。结论AMI伴CS患者行PCI术前应用IABP较术后应用IABP更能改善血流动力学指标,减轻心肌受损,提高心功能。 展开更多
关键词 主动脉内球囊反搏泵 急性心肌梗死 心源性休克 经皮冠状动脉介入术 血流动力学 心功能 心肌损伤
下载PDF
无创血流动力学监测在心血管领域的临床应用
20
作者 文人平 汪顺银 《中国社区医师》 2024年第4期7-9,共3页
心血管疾病具有发病率高、死亡率高的特点,患者需要及时进行诊断,以获得针对性治疗方案。血流动力学监测能够早期预测心血管的病理生理变化,为心血管疾病的诊断、进一步治疗提供依据。无创血流动力学监测成为近年来的研究热点,具有实时... 心血管疾病具有发病率高、死亡率高的特点,患者需要及时进行诊断,以获得针对性治疗方案。血流动力学监测能够早期预测心血管的病理生理变化,为心血管疾病的诊断、进一步治疗提供依据。无创血流动力学监测成为近年来的研究热点,具有实时、无创、连续监测的优点,已成为心血管疾病辅助检查中的重要手段,可以准确反映心脏功能的动态变化。该文阐述了无创血流动力学监测在高血压、冠心病、心力衰竭及心源性休克等心血管疾病中的应用进展。 展开更多
关键词 无创血流动力学 高血压 冠心病 心力衰竭 心源性休克
下载PDF
上一页 1 2 11 下一页 到第
使用帮助 返回顶部